Matthew Perrone, Author at Daily Hampshire Gazette - Page 2 of 7

President Joe Biden speaks in the Rose Garden of the White House in Washington, Friday, May 13, 2022, during an event to highlight state and local leaders who are investing American Rescue Plan funding. (AP Photo/Andrew Harnik)

News

Formula plant set to reopen soon

by Zeke Miller Associated Press, and Matthew Perrone Associated PressMay 16, 2022

FILE - Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

News

FDA OKs another COVID booster for 50 and up

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressMarch 29, 2022

A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore., Monday, Dec. 27, 2021. U.S. regulators have granted full approval to Moderna’s COVID-19 vaccine after reviewing additional data on its safety and effectiveness. The decision Monday, Jan. 31, 2022 by the Food and Drug Administration comes after many tens of millions of Americans have already received the shot under its original emergency authorization. Full approval means FDA has...

News

US fully approves Moderna COVID vaccine

by Matthew Perrone Associated PressJanuary 31, 2022

A United States government website is displayed on a computer, Wednesday, Jan. 19, 2022, in Walpole, Mass., that features a page where people can order free, at-home COVID-19 tests. The website, COVIDTests.gov, allows people to order four at-home tests per residence and have them delivered by mail. (AP Photo/Steven Senne)

News

US starts offering free COVID tests

by Matthew Perrone Associated Press, and Kate Brumback Associated PressJanuary 19, 2022

This image provided by Pfizer in October shows the company’s COVID-19 Paxlovid pills. U.S. health regulators on Wednesday, Dec. 22, 2021 authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.

News

US approves Pfizer pill as home COVID-19 treatment

by Matthew Perrone Associated PressDecember 22, 2021

FILE - This undated image provided by Pfizer in November 2021 shows the company's COVID-19 pills. On Tuesday, Dec. 14, 2021, Pfizer said that its experimental COVID-19 pill is effective against the omicron variant and maintained its promising early performance against the virus in final testing. (Pfizer via AP, File)

News

Pfizer confirms COVID pill’s results, potency versus omicron

by Matthew Perrone Associated PressDecember 14, 2021

FILE - This undated file image provided by Merck & Co. shows their new antiviral medication. U.S. health officials say Merck's experimental COVID-19 pill is effective but raises safety issues for pregnant women. The Food and Drug Administration posted its review Friday, Nov. 26, 2021 ahead of a public meeting next week where outside experts will debate the drug's benefits and risks. (Merck & Co. via AP, File)

News

FDA: Merck COVID pill effective, experts will review safety

by Matthew Perrone Associated PressNovember 26, 2021

FILE - This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday, Nov. 5, 2021 it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. (NIAID-RML via AP)

News

Pfizer says COVID-19 pill cut hospital, death risk by 90%

by Matthew Perrone Associated PressNovember 5, 2021

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. Kid-size doses of Pfizer’s COVID-19 vaccine may be getting closer as government advisers on Tuesday, Oct. 25, 2021 began deliberating whether there’s enough evidence that the shots are safe and effective for 5- to 11-year-olds. (Pfizer via AP)

News

FDA advisers back Pfizer’s vaccine for kids

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressOctober 26, 2021

FILE - This Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots this week in an effort to provide flexibility for those seeking to maintain protection against the coronavirus. The upcoming announcement by the Food and Drug Administration is likely to come along with authorization for boosters of the...

News

FDA OKs mixing vaccines; backs Moderna, J&J boosters

by Matthew Perrone Associated Press, and Lauran Neergaard Associated PressOctober 20, 2021